Board

EnXray's Board of Directors has a very unique and strong combination of skills and experience with guiding early stage life science and medical technology companies from early stage into growth phase.
Renee Aguiar-Lucander
Chairman
​Renee was appointed as the Chair of EnXray's Board in October 2015 and brings many years of experience in investment banking both from the USA as well as Europe, working primarily with M&A and financings of growth companies. She sits on the Board of Scibase AB and Simparel Inc and is a Director at RAL Capital and Managing Partner at Positive Capital Partners. Earlier, Renee was a partner at Omega Fund Management, where she headed up the London Office. Before Omega, Renee was a member of the Venture Group of 3i Group Plc in London focusing on European healthcare investments as well as managing the public portfolio. Prior to that she was Managing Director in investment banking at Lehman Brothers, with a focus on Business Media and internet before which she worked for 5 years in European sales and marketing for a financial services focused software business.
 
Renee holds a B.A. in Finance from Stockholm School of Economics and an MBA from INSEAD.
MARC D'ABBADIE
NON-EXECUTIVE DIRECTOR
​Marc is representative of North West Fund for Biomedical (NWFfB) Directors Ltd. and is an Investor Director at SPARK Impact and a member of the NWFfB Investment Committee.
 
Previously, Marc was an investment manager at London-based Inventages, which manages one of the world’s largest life science focused venture capital funds with assets of $1.5bn. Before that, Marc worked at Technikos, a medical device venture capital investor. He was also a consultant at McKinsey & Co., where he worked with large public companies from sectors including financial services and pharmaceuticals.
 
Marc obtained his M.A. in Natural Sciences from Trinity College and his Ph.D. in Biochemistry from the MRC Laboratory of Molecular Biology, both at the University of Cambridge. He is also a Fellow of the Royal Society of Medicine.
Julie Rasmussen
Non-Executive Director
Julie joined the Board at EnXray in September 2015 and brings many years of experience of successfully assisting CEOs and boards of emerging growth companies in building a solid base to sustain future growth. Julie serves as Partner in Newport Board Group, helping emerging growth, middle market and private equity clients navigate transitions and improve performance. She is a member of the Board of Directors at CVSL Inc., and of the National Advisory Committee for the Harriman Institute. Julie is also Majority Owner and Chairman of Hertz Russia and CEO and Owner of Dagmar Associates for private residential real estate development in Russia.

Julie previously served as president of Mary Kay Europe, during which time she restructured operations in the region and significantly increased sales and profitability.  Prior to that, she launched Mary Kay's operations in Russia serving as its president for a decade. She also launched and led the Hertz franchise in Russia and has launched and managed businesses in apparel, food and beverage and security. She has advised many companies on doing business in Russia and served on the board of the American Chamber of Commerce in Russia as well as president of the Russian Federation of Direct Selling Companies.  She has received numerous awards and honors for her international business achievements. 
 
She received her B.A. from the University of Virginia and her M.A. in international affairs from Columbia University, where she was editor of the Journal of International Affairs.
Edward Cappabianca
CEO
 Ed is responsible for all aspects of EnXray's management and looks after the relationships with key stakeholders of the company, including partners, shareholders and investors. He has extensive experience investing and fundraising as a finance professional having managed investments, including the largest USA based manufacturers’ of Ambulance and Paramedic vehicles with a turnover in excess of $100M.

He previously served as President and CEO of AmpliPhi Biosciences Corporation and Biocontrol Ltd, where he led on capital raising and corporate development. Prior to that, Ed was involved with management and development of early stage biotechnology and medical device companies with a focus on capital raising, serving as Senior Vice President for Rodman & Renshaw LLC's, Principal at CapitalinQ Ltd, and Senior Vice President of TransOcean Capital, Inc. Early in his career he was employed at Lion Capital Advisers Ltd, as Principal and William Blair International Ltd, specializing in cross border corporate finance and since 1987 with Alex Brown & Sons Inc, Paribas Capital Markets and Wertheim Schroder & Co. Inc.

Ed also serves as the Senior Partner of XOventure International and Managing Director of CapeWhite Consulting Ltd, responsible for advising growth-orientated life science companies on financing strategy.

Ed received his BA in Chemistry from the University of Virginia and MA in Business Administration from the Wharton School of the University of Pennsylvania.  
Yuri Udalov
CTO
​Yuri is responsible for the scientific and technological development of EnXray's technology and activities relating to commercial and business intelligence. He is also Strategy Advisor at Steray V.O.F., providing consultancy services in the area of engineering physics, and CTO and Co-Founder of Eye on Air, leading the development of equipment trace detection in the area of airport security. He is also Founder and Co-Director of Foundation IDEA providing consultancy.
 
Yuri began his career as and engineer at the P.N. Lebedev Physics Institute, Academy of Sciences in Russia and has over 20 years’ experience of working as research associate with technology companies. He has published over 120 articles in peer-reviewed journals and also has several patented inventions.
 
Yuri holds a Ph.D. in Frequency Stabilization and Frequency Tuning of Infrared Gas Lasers, from the P. N. Lebedev Physics Institute, Russia.
  ❮ Management
Markets ❯